SPDR Gold Trust vs Teladoc Health Inc — how do they compare? SPDR Gold Trust trades at $384.58 (market cap $139.66B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: SPDR Gold Trust is far larger — about 138.3× Teladoc Health Inc's market cap, and SPDR Gold Trust is more actively traded (9,544,773 versus 4,668,477). Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 74 Days and Teladoc Health Inc for 39 Days on average.
| GLD | TDOC | |
|---|---|---|
Market Cap | $139.66B | $1.01B |
Volume | 9,544,773 | 4,668,477 |
52-Week High | $495.90 | $9.72 |
52-Week Low | $362.32 | $4.47 |
Typical Hold Time | 74 Days | 39 Days |
Sector | — | Health |
Enterprise Value | — | $1.27B |
Signals from Pluang's Aura AI — not financial advice
GLD, the SPDR Gold Trust ETF, is trading at $378.67 with a modest 0.74% daily gain amid ongoing pressure from rising Treasury yields and Federal Reserve policy uncertainty. Technical indicators show a bearish bias with 17 sell signals versus 2 buy signals, while fundamental analysis is limited for this commodity-based ETF. Recent news highlights gold's struggle to maintain momentum despite safe-haven demand, with prices testing key support levels as bond market dynamics dominate the narrative.
The outlook for GLD remains challenged by persistent rate hike expectations and dollar strength, though strategic allocations to gold as a portfolio diversifier continue to be recommended. Key risks include further yield increases and potential break below $4,000 support, while opportunities exist for tactical positions if Fed policy becomes more dovish or geopolitical tensions escalate.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →